HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms-Reference-Cited by-同舟云学术

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

Published:2010-02 Issue:2 Volume:20 Page:112-120
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Hartkoorn Ruben C.,Kwan Wai San,Shallcross Victoria,Chaikan Ammara,Liptrott Neill,Egan Deirdre,Sora Enrique Salcedo,James Chloë E.,Gibbons Sara,Bray Pat G.,Back David J.,Khoo Saye H.,Owen Andrew

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference51 articles.

1. Host determinants of antiretroviral drug activity;Boffito;Curr Opin Infect Dis,2005

2. Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support;Khoo;J Acquir Immune Defic Syndr,2006

3. Therapeutic drug monitoring in HIV infection: current status and future directions;Back;AIDS,2002

4. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients;Marzolini;AIDS,2001

5. High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals;Veldkamp;AIDS,2001

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition;Biochemical Pharmacology;2024-03

2. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

3. Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition;Pharmaceutics;2023-10-16

4. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimen;British Journal of Clinical Pharmacology;2023-05-12

5. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox;Biochemical Pharmacology;2023-03